PDF News ArticlePortfolio

Non-Sponsor Growth Debt – Kreos Capital & Pharming Report

By 11/05/2017June 4th, 2021No Comments

Pharming wanted to buy back the rights to its own drug, but didn’t have the backing to pull it off. Kreos Capital had a remedy, writes Nathan Williams from Private Debt Investor Magazine.

Read the full report here.